Award
Delivery Order #36C26026F0298
Delivery Order for PYLARIFY Injections to Progenics Pharmaceuticals
Buyer
Department of Veterans Affairs
Award Amount
$469,133.60
Ceiling
$469,133.60
Awarded
July 01, 2026
Period of Performance
Jul 01, 2026 – Oct 31, 2026
Identifier
36C26026F0298
NAICS
325412
This award is a delivery order contract issued under an existing federal supply schedule indefinite delivery vehicle (IDV) contract held by Progenics Pharmaceuticals Inc., a specialized pharmaceutical company. The contract covers the procurement of PYLARIFY (Piflufolastat F 18) injections, a significant PET imaging agent used for advanced prostate cancer diagnostics. This procurement is crucial for the agency's medical imaging capabilities, enabling accurate and timely diagnosis. The scope involves delivering these specialized pharmaceutical injections to a production location in Bedford, MA, within a defined multi-month timeframe. The original award was competitively procured, reflecting Progenics Pharmaceuticals' established role as an essential supplier of advanced pharmaceutical products. The timeline for this delivery order spans several months in the year 2026, aligned with ongoing government medical supply needs. This order leverages the broader federal supply schedule contract which facilitates streamlined acquisition of vital drug products for federal healthcare applications.
Description
PYLARIFY (PIFLUFOLASTAT F 18) INJECTIONS